LONDON, Oct 1- Extending treatment with Roche's. breast cancer drug Herceptin to two years from the one year current standard is not worth while, trial data showed on Monday, but shortening treatment to six months also looks unlikely to benefit patients.
Earlier in the session, shares of Papa Johns were up as much as 20.8 percent, their best one-day gain ever.
The Obama Administration's plan to stem foreclosures and the Fed's latest view on the economy are two powerful catalysts for markets Wednesday.
Plunging commodities combined with weakness in energy and basic materials dragged down the Dow as well as the broader stock market. What's the word on the Street?